RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER-negative breast cancer models
Authors:
- Sebastien TaurinSTSebastien Taurin
- Lesley LarsenLLLesley Larsen
- Rhonda J. RosengrenRRRhonda J. Rosengren
- 11 September 2012
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 41 (5) , 1723-1732
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 42 references indexed in Scilit:
- Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivoEndocrine-Related Cancer, 2009
- Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/β-catenin signalingChemico-Biological Interactions, 2009
- Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFκB, cyclinD and MMP-1 transcriptionPhytomedicine, 2009
- Curcumin Suppresses the Paclitaxel-Induced Nuclear Factor-κB in Breast Cancer Cells and Potentiates the Growth Inhibitory Effect of Paclitaxel in a Breast Cancer Nude Mice ModelThe Breast Journal, 2009
- Biological activities of curcumin and its analogues (Congeners) made by man and Mother NatureBiochemical Pharmacology, 2008
- The combination of epigallocatechin gallate and curcumin suppresses ERα‐breast cancer cell growth in vitro and in vivoInternational Journal of Cancer, 2008
- An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgenOncogene, 2006
- Chemoprevention by curcumin during the promotion stage of tumorigenesis of mammary gland in rats irradiated with gamma-raysCarcinogenesis, 1999
- Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7, 12-dimethylbenz[a]anthracene-induced mammary cancer in ratsCarcinogenesis, 1996
- Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic gradingCancer, 1984